-+ 0.00%
-+ 0.00%
-+ 0.00%

Argenx Posts Growth in Q3 Attributable Profit, Product Net Sales

MT Newswires·10/22/2026 01:40:28
Listen to the news
01:40 AM EDT, 10/22/2026 (MT Newswires) -- Argenx (ARGX.BR) logged $506 million in profit attributable to owners of the parent for the third quarter, compared with $344 million a year ago. EPS moved to $7.80 from $5.18 year over year, a Thursday filing showed. For the three months ended Sept. 30, product net sales were $1.72 billion versus $1.13 billion previously, the immunology company added.